- Nachrichtendetail
-
16.05.2024 13:48:21 - dpa-AFX: *LILLY : PHASE 3 TRIALS OF ONCE-WEEKLY INSULIN IN TYPE 2 DIABETES MEETS PRIMARY ENDPOINT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Eli Lilly & Co | 858560 | NYSE | 891,743 | 18.06.24 21:58:25 | +6,733 | +0,76% | 891,550 | 892,000 | 878,000 | 885,010 |
